President Donald Trump signs an executive order to reclassify marijuana as a Schedule III drug SummaryPresident Trump signed an executive order on December 18, 2025, directing agencies to expedite the rescheduling of marijuana from Schedule I to Schedule III under the Controlled Substances Act, facilitating expanded medical research while not legalizing it nationwide. CMS Administrator Mehmet Oz announced that the CMS Innovation Center is launching models allowing millions of Medicare beneficiaries to access doctor-recommended hemp-derived CBD products at no cost starting as early as April 2026, provided products meet state and local quality/safety standards and come from legitimate sources. Patients...